Former Chief Research and Development Strategy Officer · Protagonist Therapeutics, Inc (PTGX)

David Liu

A named executive officer of Protagonist Therapeutics in every fiscal year CompBrief holds from FY2017 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$2,248,806

Salary $475,000Stock awards $287,300

FY2021: $2,070,827

3rd of 3 named executive officers at Protagonist Therapeutics by FY2022 total.

3 named officers on file for Protagonist Therapeutics, FY2022

David Liu’s pay file — $29

  • 6 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • PTGX’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Protagonist Therapeutics’s whole pay program stands against its peers

  • Protagonist Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PTGX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 12, 2023 (DEF 14A).

Free

Get David Liu’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

David Liu compensation by year

Protagonist Therapeutics Summary Compensation Table · all 6 fiscal years held
In US dollars, as Protagonist Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021FY2022
Salary$357,000$410,000$428,450$441,300$455,000$475,000
Bonus$0$0$0$0$0$0
Stock awards$0$382,389$120,300$0$235,700$287,300
Option awards$0$677,008$424,881$352,429$1,132,261$1,347,828
Non-equity incentive$186,000$141,500$218,509$266,987$233,188$123,500
Pension and deferred compensation$0$0$0$0$0$0
All other$9,168$7,458$7,458$11,133$14,678$15,178
Total$552,168$1,618,355$1,199,598$1,071,849$2,070,827$2,248,806

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Protagonist Therapeutics, Inc DEF 14A filed April 12, 2023, accession 0001104659-23-044557, and prior-year filings.

How this page was built: the Protagonist Therapeutics, Inc filed document, accession 0001104659-23-044557. Every figure is read from that document and cited to the page and table it appears in. Filed April 12, 2023.

$552K
$1.6M
$1.2M
$1.1M
$2.1M
$2.2M
FY17
FY18
FY19
FY20
FY21
FY22
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
PSU12,000$130,920—
RSU10,000$109,100—
PSU10,000$109,100—
RSU10,000$109,100—
RSU3,750$40,913—
Option35,209—$23.57
Option47,500—$28.73
Option20,417—$7.80
Option3,750—$8.02

Per the Outstanding Equity Awards at Fiscal Year-End table in Protagonist Therapeutics, Inc's FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Protagonist Therapeutics’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Dinesh PatelPresident and Chief Executive Officer$5,993,238
Suneel GuptaChief Development Officer$2,684,804
David Liu · this pageFormer Chief Research and Development Strategy Officer$2,248,806

The full Protagonist Therapeutics compensation record

free company brief

This page is one person within Protagonist Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Protagonist Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Protagonist Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

David Liu's compensation dossier · One-time report. No refunds.